2024-520126-11-00CompletedPhase 1
A study to Learn If Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 20 May 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- First submitted
- 4 Feb 2025
- Start date
- 14 Mar 2025
- Lead sponsor
- Pfizer Inc.
- EU CT number
- 2024-520126-11-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 8
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pfizer Clinical Research Unit | Brussels | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.